Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
FB Care Service Co.,Ltd. (9220.T)
Saku, JP
Founded in 1987 and headquartered in Saku, Japan, FB Care Service Co.,Ltd. delivers a broad array of elder care solutions, operating both within Japan and on an international scale. The company's activities are divided into two primary divisions: direct nursing and welfare equipment. Within its care offerings, FB Care Service manages various facilities, including private, fee-based nursing homes and community-based group residences. It also provides specialized integrated small-scale home and nursing support, daily activity programs, at-home personal care and medical visits, and guidance for in-home care arrangements. Furthermore, the company assists clients by renting and selling essential assistive devices.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.65% | -3.08% | +0.33% | +1.24% | -0.81% | +4.69% | +24.29% | +17.18% | -29.18% | -29.18% | -29.18% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+5.2% Q1'26: +6.4% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+19.9% ★ Q1'26: -52.1% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+7.4% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+5.5% Q1'26: +5.5% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+9.6% ★ Q1'26: +8.7% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%-7.3% ★ Q1'26: -13.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×2.50× ★ Q1'26: 2.51× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
|---|---|---|---|
| Revenue |
9.19B
est: 9.19B (0.0%)
|
9.62B
est: 9.49B (+1.3%)
|
10.36B
est: 10.34B (+0.2%)
|
| EBITDA |
963.55M
est: 1.00B (-3.7%)
|
863.46M
est: 1.03B (-16.5%)
|
900.32M
est: 970.99M (-7.3%)
|
| EBIT |
649.52M
est: 679.98M (-4.5%)
|
544.27M
est: 702.59M (-22.5%)
|
527.40M
est: 609.40M (-13.5%)
|
| Net Income |
528.70M
est: 610.73M (-13.4%)
|
444.93M
est: 534.94M (-16.8%)
|
523.43M
est: 650.43M (-19.5%)
|
| SGA |
684.53M
est: 772.22M (-11.4%)
|
764.69M
est: 797.90M (-4.2%)
|
703.25M
est: 764.74M (-8.0%)
|
| EPS |
207.33
est: 228.45 (-9.2%)
|
167.39
est: 200.10 (-16.3%)
|
195.60
est: 243.30 (-19.6%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | B | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-14 | B | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-13 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-12 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-11 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-08 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-07 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-01 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-30 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-28 | A- | 4/5 | 1/5 | 4/5 | 5/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-27 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-23 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dairi Yoda | IR Planning Officer & Director | — | male |
| Miho Yanagizawa | President & Representative Director | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 9220.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
